Transgene SA
Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. It is involved in developing TG4050, a therapeutic vaccine that is in phase I clini…
Biotechnology
FR, Illkirch-Graffenstaden [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Transgene SA (TNG.PA) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology Average | - - | - - | - - | 309,362.06 | 17,997.71 | 1,149.66 | 689.34 | 921.32 | 0.00 | 27.4111 | 41.05 | -0.6652 | -17.6128 | -0.07 | -0.07 | 6.5625 | - - | |
| Maximum | - - | - - | - - | 39,973,011.00 | 881,933.00 | 85,592.00 | 99,050.00 | 262,089.00 | 0.02 | 1,336.3467 | 2,849.43 | 3.0051 | 85.3485 | 0.38 | 8.35 | 61.5621 | - - | |
| Minimum | - - | - - | - - | 0.00 | 0.00 | -10,603.00 | -56,335.00 | -50,658.00 | 0.00 | -233.7460 | -132.82 | -101.7758 | -1,444.7800 | -1.56 | -12.64 | 0.0000 | - - | |
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.